OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

2021 update on thyroid-associated ophthalmopathy
Emily Neag, Terry J. Smith
Journal of Endocrinological Investigation (2021) Vol. 45, Iss. 2, pp. 235-259
Open Access | Times Cited: 74

Showing 1-25 of 74 citing articles:

Current concepts regarding Graves’ orbitopathy
Luigi Bartalena, Maria Laura Tanda
Journal of Internal Medicine (2022) Vol. 292, Iss. 5, pp. 692-716
Open Access | Times Cited: 107

The role of autophagy in Graves disease: knowns and unknowns
Hayder M. Al‐kuraishy, Ghassan M. Sulaiman, Hamdoon A. Mohammed, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 12
Open Access | Times Cited: 2

Obesity and Thyroid Cancer Risk: An Update
Fabiana Franchini, Giuseppe Palatucci, Annamaria Colao, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 3, pp. 1116-1116
Open Access | Times Cited: 63

Thyroid Eye Disease: Epidemiology, Natural History, and Risk Factors
Luigi Bartalena, Daniela Gallo, Maria Laura Tanda, et al.
Ophthalmic Plastic and Reconstructive Surgery (2023) Vol. 39, Iss. 6S, pp. S2-S8
Closed Access | Times Cited: 19

Understanding Pathogenesis Intersects With Effective Treatment for Thyroid Eye Disease
Terry J. Smith
The Journal of Clinical Endocrinology & Metabolism (2022) Vol. 107, Iss. Supplement_1, pp. S13-S26
Open Access | Times Cited: 25

Dysthyroid optic neuropathy: emerging treatment strategies
Maryla Pelewicz-Sowa, Piotr Miśkiewicz
Journal of Endocrinological Investigation (2023) Vol. 46, Iss. 7, pp. 1305-1316
Open Access | Times Cited: 15

Altered dynamic brain activity and functional connectivity in thyroid‐associated ophthalmopathy
Wen‐Hao Jiang, Jun Liu, Jiang Zhou, et al.
Human Brain Mapping (2023) Vol. 44, Iss. 16, pp. 5346-5356
Open Access | Times Cited: 14

SOX9 Induces Orbital Fibroblast Activation in Thyroid Eye Disease Via MAPK/ERK1/2 Pathway
Min Zhou, Bingying Lin, Pengsen Wu, et al.
Investigative Ophthalmology & Visual Science (2024) Vol. 65, Iss. 2, pp. 25-25
Open Access | Times Cited: 5

Early diagnosis of thyroid-associated ophthalmopathy using label-free Raman spectroscopy and multivariate analysis
Zhihong Wang, Weiming Lin, Chenyu Luo, et al.
Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy (2024) Vol. 310, pp. 123905-123905
Closed Access | Times Cited: 4

Thyroid-associated ophthalmopathy: the role of oxidative stress
Chao Ma, Haoyu Li, Shuwen Lu, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 4

Development of New Drugs for Autoimmune Hemolytic Anemia
Zhengrui Xiao, Irina Murakhovskaya
Pharmaceutics (2022) Vol. 14, Iss. 5, pp. 1035-1035
Open Access | Times Cited: 19

Facial expression of patients with Graves’ orbitopathy
Changjiang Lei, Miao Qu, Hanxing Sun, et al.
Journal of Endocrinological Investigation (2023) Vol. 46, Iss. 10, pp. 2055-2066
Closed Access | Times Cited: 10

Predictive markers for anti-inflammatory treatment response in thyroid eye disease
Haiyang Zhang, Jingyuan Fan, Jialu Qu, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 10

Evaluation of the clinical management of Graves’ Orbitopathy according to severity: a real-life Analysis
Antonio Manuel Garrido Hermosilla, María Concepción Díaz-Ruiz, Reyes Ravé-García, et al.
International Ophthalmology (2025) Vol. 45, Iss. 1
Closed Access

S-phase kinase-associated protein 1 inhibits orbital fibroblasts adipogenesis to improve thyroid-associated ophthalmopathy (TAO)
Shi Yao Lu, Wei Xiong, Jinping Yi, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2025), pp. 119937-119937
Closed Access

Decoding B Cells in Autoimmune Diseases Through ScRNA + BCR-Seq: Current Knowledge and Future Directions
Kai Quan, Huifang Wang, Peng Su, et al.
Cells (2025) Vol. 14, Iss. 7, pp. 539-539
Open Access

The burden of illness in thyroid eye disease: current state of the evidence
Madhura A. Tamhankar, Syed Raza, Erika Brutsaert, et al.
Frontiers in Ophthalmology (2025) Vol. 5
Open Access

Thyroid Eye disease in the Biologic Era: a 40-year paradigm shift in nonsurgical therapeutic strategies
Erqian Wang, Zuyi Yang, Ziyan Xie, et al.
Expert Review of Clinical Immunology (2025)
Open Access

Natural compounds efficacy in Ophthalmic Diseases: A new twist impacting ferroptosis
Mengxia Yuan, Qi He, Xiang Wang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 172, pp. 116230-116230
Open Access | Times Cited: 3

Autoimmune thyroid diseases
Luigi Bartalena, Daniela Gallo, Maria Laura Tanda
Elsevier eBooks (2024), pp. 561-584
Closed Access | Times Cited: 3

Ocular immune‐related diseases: molecular mechanisms and therapy
Yakun Wang, Shangze Gao, Fan Cao, et al.
MedComm (2024) Vol. 5, Iss. 12
Closed Access | Times Cited: 3

CD34+ orbital fibroblasts contribute to the pathogenesis of thyroid eye disease via miR-182-5p
Bin Yu, Yi Wang, Jun‐O Jin, et al.
The Journal of Clinical Endocrinology & Metabolism (2024)
Open Access | Times Cited: 3

Potential Therapeutic Activity of Berberine in Thyroid-Associated Ophthalmopathy: Inhibitory Effects on Tissue Remodeling in Orbital Fibroblasts
Jiale Diao, Xinxin Chen, Pei Mou, et al.
Investigative Ophthalmology & Visual Science (2022) Vol. 63, Iss. 10, pp. 6-6
Open Access | Times Cited: 14

Page 1 - Next Page

Scroll to top